Trial Profile
Randomised double-blinded phase II AIDS vaccine study comparing immunogenicity and safety of 3 doses of lipopeptide (LIPO-5) [HIV vaccine] versus placebo in non infected HIV volunteers (ANRS VAC 18)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Anti-HIV lipopeptide vaccine (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics
- 09 Jul 2010 Results have been published in AIDS.
- 05 Jun 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
- 02 Jul 2007 Status changed from recruiting to in progress.